Skip to main page content

Brian G. Ballios, MD, PhD, FRCSC, DABO

Invited Speaker
Uczestniczy w 2 elementy

{"twitch"=>"", "youtube"=>"", "linkedin"=>"", "flickr"=>"", "bio"=>"", "reddit"=>"", "facebook"=>"", "website"=>"", "twitterinfo"=>"", "othersocialmedia"=>"", "instagram"=>""}

Elementy, w których Brian G. Ballios, MD, PhD, FRCSC, DABO uczestniczy

sobota 11 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
13:15
13:17 - 13:24 | 7 min.
Ocular Regenerative Medicine

sobota 17 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

Elementy, w których Brian G. Ballios, MD, PhD, FRCSC, DABO attends

sobota 11 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
5:30
5:30 - 7:00 | 1 godz. 30 min.
Co-Developed Symposium

Innovation in Retina Research Award Learning ObjectivesAt the end of this symposium, participants will be able to:Identify innovative Canadian retina research proposals and their intended benefitDescribe how using digital innovations in ophthalmology can optimize patie...

9:45
9:45 - 11:15 | 1 godz. 30 min.
Retina

Learning ObjectivesAt the end of this session, participants will be able to:Assess and manage vitreoretinal lymphomaDescribe the choroidal changes in the treatment of diabetic retinopathyIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar 

9:45 - 11:15 | 1 godz. 30 min.
Cornea

Learning Objectives:To review treatment strategies for managing intraocular lens complicationsTo review pearls for performing cataract surgery in patients with corneal conditions.To understand healthcare economics associated with ocular surface disease and cataract surgeryCanMEDS Roles: Medical expert; Scholar

12:30
12:30 - 14:00 | 1 godz. 30 min.
Retina

Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar

12:30 - 14:00 | 1 godz. 30 min.
Ocular Regenerative Medicine

Learning ObjectivesAt the end of this session, participants will be able to:Define the signs and symptoms of Limbal Stem Cell DeficiencyDescribe the treatment modalities currently in use to treat Limbal Stem Cell DeficiencyDescribe how gene-based therapy is used to treat retinal diseaseDescribe how cell-based therapy is used to treat retinal diseaseCanMEDS Roles: Medical Expert, Professional

14:45
14:45 - 16:15 | 1 godz. 30 min.
Retina

Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar

15:00
15:02 - 15:09 | 7 min.
Retina

Authors: Varun Chaudhary, Jean-François Korobelnik, Paul Mitchell, Se Woong Kang, Ramin Tadayoni, Helmut Allmeier, JinKyung Lee, Tobias Machewitz, Kristian T. Johnson, Clare Bailey. Author Disclosure Block: V. Chaudhary: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Novartis, Bayer. Any direct financial payments including receipt of honoraria; Description of relationship(s); Spe...

15:35
15:37 - 15:44 | 7 min.
Retina

Authors: Imaan Z. Kherani1, Chad Andrews2, Jennifer Pereira3, Larissa Moniz4, Cynthia X. Qian5. 1Temerty Faculty of Medicine, University of Toronto, 2College of Optometrists of Ontario, 3JRL Research & Consulting Inc., 4Fighting Blindness Canada, 5Department of Ophthalmology, Universite de Montreal.Author Disclosure Block: I.Z. Kherani: None. C. Andrews: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Fighting Blin...

15:55
15:59 - 16:06 | 7 min.
Retina

Authors: Ellen Tianwei Zhou, Pierre-Olivier Kassis, Cynthia Qian, Patrick Hamel, Sylvain Chemtob, Anne-Monique Nuyt, Thuy Mai Luu.Author Disclosure Block: E.T. Zhou: None. P. Kassis: None. C. Qian: None. P. Hamel: None. S. Chemtob: None. A. Nuyt: None. T. Luu: None.Purpose: Retinopathy of prematurity (ROP) remains the dominant cause of severe visual impairment in childhood in North America and Europe. With the improvement in ne...

niedziela 12 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
5:30
5:30 - 7:00 | 1 godz. 30 min.
Co-Developed Symposium

LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...

8:25
8:25 - 8:30 | 5 min.
Current ConceptsAwards
8:30
9:45
9:45 - 11:15 | 1 godz. 30 min.
Retina

Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...